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Abstract
Background: A small subset of patients have dysfunctional maxillary sinus mucosa. These patients require more aggressive surgical treatment to allow for gravity dependent mucous
drainage, intra-operative and office debridements, and the delivery of irrigations and topical treatments. The aim of this study is to examine the use of inferior meatus maxillary
antrostomy (IMMA) in combination with traditional maxillary antrostomy, in this challenging patient population.
Methods: We performed a retrospective study from February, 2008 until April, 2014 with a 118 patients undergoing a total of 128 IMMA procedures. Data was gathered regarding
patient demographic, prior therapy, post-operative medical therapy, IMMA patency, SNOT-22 scores, Lund Mackay score, and the presence of disease recurrence.
Results: 118 patients (mean age 53) underwent 128 IMMA procedures. The mean length of follow-up was 1.6 years, and 66 % of patients had previous sinus surgery. 62 operations
were for recalcitrant maxillary sinus disease, 36 for recalcitrant polyp disease, 6 for maxillary fungal disease, 4 for mucosal disease and 20 for odontogenic infections. 49 patients
completed both pre and post-operative SNOT-22 scores, and the mean scores were 39 and 21, respectively. At 3 months post-operatively, we found that patients undergoing revision
surgery and patients with nasal polyposis had the greatest SNOT-22 improvement. Males had 64% less SNOT-22 improvement compared to women at 3 months post operatively. In
addition, 18% of patients did not experience any symptomatic improvement at 3 months post-operatively. With regards to post-operative medical therapy, men were more likely to
have been prescribed steroid irrigations and antibiotics. Patients with fungal sinusitis had the greatest need for post-operative steroids. In addition, increased age correlated to
fewer post-operative steroid courses. Out of 202 total inferior windows, 197 were patent post-operatively. There were 9 patients requiring revision surgery for maxillary sinus
disease following IMMA, and patients requiring revision had the poorest outcomes.
Conclusion: Inferior meatal windows prove to be efficacious in patients with mucocillaray dysfunction without disrupting the normal mucociliary flow pattern. The inferior turbinate
is also preserved, which may be a less destructive alternative to a mega antrostomies. We have determined that IMMA is a safe and successful procedure for chronic maxillary sinus
pathology.
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Table 1. Demographics
Patients in study
118
Male
69
Female
49
Age, mean ± SD
52.7 ± 13.8
Follow-up (years),
1.6 ± 1.5
mean ± SD
Previous sinus surgery, %
66 (78/118)
(No)
Total Inferior windows
233
Bilateral procedures
105
Unilateral procedures
23
Table 1. Patient demographics are shown,
in addition to the total number of inferior
windows created in a total of 128
procedures.
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With IRB approval, we performed a
retrospective chart review of a subset
of patients who underwent IMMA for
chronically dysfunctional maxillary
mucosa from February, 2008 to April,
2014.
• Data collection: diagnosis,
comorbidities, age, previous sinus
surgery, SNOT-22 scores, length of
follow-up, post-operative
complications, patency of pre and
post-operative CT scans, pre
operative Lund-Mackay score, and
post-operative medical therapy.
• Postoperative success: patency of
the inferior window, SNOT-22
improvement, and requirement of
revision surgery for irresolvable
maxillary sinus disease.
• Patient diagnoses: recalcitrant CRS
with or without nasal polyposis,
maxillary fungal disease, mucosal
disease, or odontogenic infection.
• Exclusions: patients with inverted
papilloma or other oncogenic
condition.

PERCENT PATIENTS RECEIVING
THERAPY

Materials and Methods

Steroid Irrigation
≥11

Figure 4. Post-operative medical therapy. The total number of antibiotic, steroid
and steroid irrigation courses prescribed were tracked for each patient postoperatively. Data is reported as percent of patients per diagnosis receiving between
0-5, 6-10, or ≥ 11 courses. Patients with oroantral fistulas (OF) received fewer
courses of antibiotics, steroids, and steroid irrigations (p < 0.001). On 16 of 128
occasions, patients required no post-operative medical therapy.
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Figure 1. Patient Diagnoses. 118 patients underwent 128 IMMA procedures:
62/128 operations were for CRS (maxillary chronic rhinosinusitis), 36/128 for
CRSWNP (CRS with nasal polyposis), 6/128 for FS (fungal sinusitis), 4/128 for MD
(mucosal disease), and 20/128 for OF (oroantral fistula).

Figure 7. Intraoperative navigation with a the cross hairs depicting the
location of the inferior window
Table 3. Outcome measures
SNOT-22 data (n=49)
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Figure 5. Endoscopic view of inferior window. Out of 202 individual inferior
windows, 197 were patent post-operatively (97.5%) (Table 2). Of the 118 patients, 9
patients (7.6 %) required recurrent surgery for maxillary sinus disease following IMMA,
and 108 patients had postoperative clinical resolution. The average time to revision
was 18 months, ranging from 5 months to 50 months (Table 2). Age, gender, diagnosis
and previous sinus surgery had no statistically significant impact on likelihood of
revision.
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Table 2. Data Analysis
SNOT-22
Estimate
Significance
CI
Prior surgery
2.13
p < 0.001
1.663, 2.760
Age
0.98
p < 0.001
0.965, 0.988
Oroantral fistula
0.29
p < 0.001
0.143, 0.516
CRS with nasal polyposis
0.43
p < 0.001
0.325, 0.553
SNOT-22 3 month F/U
Estimate
Significance
CI
Age
1.01
p < 0.001
1.005, 1.016
Gender (M)
0.64
p < 0.001
0.567, 0.721
Oroantral fistula
0.60
p = 0.003
0.426, 0.838
CRS with nasal polyposis
0.79
p = 0.001
0.690, 0.914
Fungal sinusitis
0.08
p < 0.001
0.044, 0.155
Prior surgery
0.77
p < 0.001
0.672, 0.884
Antibiotics
Estimate
Significance
CI
Oroantral fistula
0.17
p < 0.001
0.092, 0.307
Gender (M)
2.45
p = 0.045
1.019, 5.867
Steroids
Estimate
Significance
CI
Age
0.98
p < 0.001
0.976, 0.991
Oroantral fistula
0.10
p < 0.001
0.046, 0.217
Fungal sinusitis
26.10
p = 0.004
2.853, 249.789
Steroid Irrigation
Estimate
Significance
CI
Gender
1.39
p = 0.022
1.048, 1.844
Age
1.06
p = 0.004
1.020, 1.111
Prior surgery
0.35
p = 0.049
0.126, 0.994
Oroantral fistula
0.20
p < 0.001
0.090, 0.436
Mucosal disease
2.02
p = 0.037
1.044, 3.926
Table 2. Poisson regression and zero-inflation Poisson regression were used
to analyze the data. Statistical significance was considered at p < 0.05.
CI – confidence interval.
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Figure 2. Pre-operative Lund-Mackay scores. Scans were scored with Lund-Mackay
scoring system. The average score for the entire population was 10.4 ± 6.7.
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Pre-operative SNOT-22, mean ± SD
Post-operative SNOT-22, mean ± SD
Revision rate, % (No)
Chronic rhinosinutis (CRS)
CRS with nasal polyposis
Fungal sinusitis

39 ± 22
20 ± 19
7.6 % (9/118)
6/9
2/9
1/9

Post-operative inferior window patency, % (No)

97.5% (197/202)

Average time to revision, months ± SD
18 ± 14
Table 3. SNOT-22, revision rate and post-operative inferior window patency
were our primary outcome measures. In addition we calculated average time
to revision for the 9 patients requiting a revision surgery.
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Figure 3. Patient demographics by diagnosis. Total patients with each diagnosis
are shown as a percent of the total population of 118 patients. Gender and prior
surgery are represented as a percent of patients with a specific diagnosis.

Figure 6. SNOT-22 scores. Patient outcomes were measured with the SNOT-22
score for a total of 49 patients who completed both pre and post-operative
SNOT-22 scores. Post-operative SNOT-22 scores were measured between 0-3
months, 3-6 months, and 6-12 months follow-up.

Figure 8. Post-operative sinus CT scans.
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